Cognition Therapeutics (CGTX) Tax Provisions (2022)

Cognition Therapeutics (CGTX) reported Tax Provisions of -$125000.0 for Q2 2022, down 200.0% on a QoQ basis from $125000.0 in Q1 2022.

Cognition Therapeutics (CGTX) has 1 years of Tax Provisions data on file, last reported at -$125000.0 in Q2 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Quantum Biopharma 1,638,563.89 Bn 1,638,563.89 Bn - -
2 Alterity Therapeutics 767,934.24 Bn 767,934.20 Bn - -
3 Legend Biotech 2,937.00 Bn 2,936.10 Bn 242.10 Mn -11.20 Mn
4 Nanobiotix 2,282.79 Bn 2,282.72 Bn - -
5 Akari Therapeutics 2,169.69 Bn 2,169.69 Bn - -859,000.00
6 Vertex Pharmaceuticals 110.41 Bn 103.16 Bn 2.59 Bn 221.50 Mn
7 Regeneron Pharmaceuticals 66.44 Bn 57.69 Bn 3.31 Bn 104.00 Mn
8 Evaxion A 65.44 Bn 65.42 Bn - 216,000.00
9 Alnylam Pharmaceuticals 39.53 Bn 36.52 Bn 959.66 Mn 15.66 Mn
10 Cognition Therapeutics 648,270.00 648,270.00 - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2022 -125,000.00
Mar 31, 2022 125,000.00